Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-24 @ 10:17 PM
NCT ID: NCT03957135
Eligibility Criteria: Inclusion Criteria: * Eastern Cooperative Oncology Group (ECOG) performance score 0-2 * Pancreatic ductal adenocarcinoma that is pathologically confirmed or shows characteristic radiologic features * Patients with resectable pancreatic cancer at the time of surgery (Including borderline resectable pancreatic cancer at the time of diagnosis or Locally advanced pancreatic cancer after chemotherapy or radiation therapy) * Lesion (within pancreatic body and tail) is located to the left of the left branch of the hepatic portal vein * No remote metastasis in preoperative imaging and not adjacent to the superior mesenteric vein, superior mesenteric artery, and abdominal artery * Patients without invasion of adjacent organs other than the left adrenal gland and mesocolon * Patients with informed consent Exclusion Criteria: * Patients with remote metastasis at the time of diagnosis of pancreatic cancer * History of other malignancy (Inclusive if there is no evidence of recurrence after 5 years of treatment) * In the case of invasion of other organs other than the left adrenal gland and mesocolon * Where major vascular resection, such as the portal vein or abdominal artery, is required to secure negative resection * Recurrent pancreatic cancer * Patients with underlying diseases at high risk of general anesthesia * Preperitoneal or other organ metastases found during surgery * In case of previously undergone pancreatic resection * Other subject whom the investigator deems inappropriate
Healthy Volunteers: True
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 80 Years
Study: NCT03957135
Study Brief:
Protocol Section: NCT03957135